
|Articles|July 10, 2015
Rep. Frank Pallone Jr. on Streamlining the Anti-Cancer Drug Approval Process
Author(s)Rep. Frank Pallone Jr.
Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses "streamlining" the FDA's drug approval process as it relates to the 21st Century Cures Act.
Advertisement
Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses “streamlining” the FDA’s drug approval process as it relates to the 21st Century Cures Act.
In a 344-77 vote this morning, the U.S. House of Representatives voted overwhelmingly to approve the 21st Century Cures Act.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
2
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
3
FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer
4
What Breast Cancer Survivors Should Know About Weight Loss and Long-Term Health
5




